ID   STT3B_HUMAN             Reviewed;         826 AA.
AC   Q8TCJ2; Q96JZ4; Q96KY7;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   10-MAY-2017, entry version 117.
DE   RecName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B;
DE            Short=Oligosaccharyl transferase subunit STT3B;
DE            Short=STT3-B;
DE            EC=2.4.99.18;
DE   AltName: Full=Source of immunodominant MHC-associated peptides homolog;
GN   Name=STT3B; Synonyms=SIMP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12439619; DOI=10.1007/s00251-002-0502-4;
RA   McBride K., Baron C., Picard S., Martin S., Boismenu D., Bell A.,
RA   Bergeron J., Perreault C.;
RT   "The model B6dom1 minor histocompatibility antigen is encoded by a
RT   mouse homolog of the yeast STT3 gene.";
RL   Immunogenetics 54:562-569(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 510-826.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 576-826.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12887896; DOI=10.1016/S1097-2765(03)00243-0;
RA   Kelleher D.J., Karaoglu D., Mandon E.C., Gilmore R.;
RT   "Oligosaccharyltransferase isoforms that contain different catalytic
RT   STT3 subunits have distinct enzymatic properties.";
RL   Mol. Cell 12:101-111(2003).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498 AND SER-499, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-29, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   FUNCTION.
RX   PubMed=19167329; DOI=10.1016/j.cell.2008.11.047;
RA   Ruiz-Canada C., Kelleher D.J., Gilmore R.;
RT   "Cotranslational and posttranslational N-glycosylation of polypeptides
RT   by distinct mammalian OST isoforms.";
RL   Cell 136:272-283(2009).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-623 AND ASN-627.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29 AND SER-498, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   FUNCTION IN ERAD PATHWAY.
RX   PubMed=22607976; DOI=10.1016/j.molcel.2012.04.015;
RA   Sato T., Sako Y., Sho M., Momohara M., Suico M.A., Shuto T.,
RA   Nishitoh H., Okiyoneda T., Kokame K., Kaneko M., Taura M., Miyata M.,
RA   Chosa K., Koga T., Morino-Koga S., Wada I., Kai H.;
RT   "STT3B-dependent posttranslational N-glycosylation as a surveillance
RT   system for secretory protein.";
RL   Mol. Cell 47:99-110(2012).
RN   [16]
RP   INVOLVEMENT IN CDG1X.
RX   PubMed=23842455; DOI=10.1093/hmg/ddt312;
RA   Shrimal S., Ng B.G., Losfeld M.E., Gilmore R., Freeze H.H.;
RT   "Mutations in STT3A and STT3B cause two congenital disorders of
RT   glycosylation.";
RL   Hum. Mol. Genet. 22:4638-4645(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-498 AND SER-499,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=25135935; DOI=10.1083/jcb.201404083;
RA   Cherepanova N.A., Shrimal S., Gilmore R.;
RT   "Oxidoreductase activity is necessary for N-glycosylation of cysteine-
RT   proximal acceptor sites in glycoproteins.";
RL   J. Cell Biol. 206:525-539(2014).
RN   [19]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=23606741; DOI=10.1242/jcs.115410;
RA   Dumax-Vorzet A., Roboti P., High S.;
RT   "OST4 is a subunit of the mammalian oligosaccharyltransferase required
RT   for efficient N-glycosylation.";
RL   J. Cell Sci. 126:2595-2606(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalytic subunit of the N-oligosaccharyl transferase
CC       (OST) complex which catalyzes the transfer of a high mannose
CC       oligosaccharide from a lipid-linked oligosaccharide donor to an
CC       asparagine residue within an Asn-X-Ser/Thr consensus motif in
CC       nascent polypeptide chains. N-glycosylation occurs
CC       cotranslationally and the complex associates with the Sec61
CC       complex at the channel-forming translocon complex that mediates
CC       protein translocation across the endoplasmic reticulum (ER). STT3B
CC       is present in a small subset of OST complexes and mediates both
CC       cotranslational and post-translational N-glycosylation of target
CC       proteins: STT3B-containing complexes are required for efficient
CC       post-translational glycosylation and while they are less competent
CC       than STT3A-containing complexes for cotranslational glycosylation,
CC       they have the ability to mediate glycosylation of some nascent
CC       sites that are not accessible for STT3A. STT3B-containing
CC       complexes also act post-translationally and mediate modification
CC       of skipped glycosylation sites in unfolded proteins. Plays a role
CC       in ER-associated degradation (ERAD) pathway that mediates
CC       ubiquitin-dependent degradation of misfolded endoplasmic reticulum
CC       proteins by mediating N-glycosylation of unfolded proteins, which
CC       are then recognized by the ERAD pathway and targeted for
CC       degradation. Mediates glycosylation of the disease variant AMYL-
CC       TTR 'Asp-38' of TTR at 'Asn-118', leading to its degradation.
CC       {ECO:0000269|PubMed:19167329, ECO:0000269|PubMed:22607976,
CC       ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY: Dolichyl diphosphooligosaccharide + [protein]-
CC       L-asparagine = dolichyl diphosphate + a glycoprotein with the
CC       oligosaccharide chain attached by N-beta-D-glycosyl linkage to a
CC       protein L-asparagine.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the oligosaccharyltransferase (OST) complex.
CC       OST exists in two different complex forms which contain common
CC       core subunits RPN1, RPN2, OST48, OST4, DAD1 and TMEM258, either
CC       STT3A or STT3B as catalytic subunits, and form-specific accessory
CC       subunits. OST can form stable complexes with the Sec61 complex or
CC       with both the Sec61 and TRAP complexes (By similarity).
CC       {ECO:0000250|UniProtKB:E2RG47, ECO:0000269|PubMed:23606741,
CC       ECO:0000269|PubMed:25135935, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:12887896}. Endoplasmic reticulum membrane;
CC       Multi-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung,
CC       liver, muscle, kidney and pancreas. Expressed in skin fibroblasts
CC       (at protein level). {ECO:0000269|PubMed:12887896}.
CC   -!- DISEASE: Congenital disorder of glycosylation 1X (CDG1X)
CC       [MIM:615597]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:23842455}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the STT3 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH15880.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB55370.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC11581.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY074880; AAL71884.1; -; mRNA.
DR   EMBL; AC104643; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK027789; BAB55370.1; ALT_INIT; mRNA.
DR   EMBL; AK075380; BAC11581.1; ALT_INIT; mRNA.
DR   EMBL; BC015880; AAH15880.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2650.1; -.
DR   RefSeq; NP_849193.1; NM_178862.2.
DR   UniGene; Hs.475812; -.
DR   ProteinModelPortal; Q8TCJ2; -.
DR   BioGrid; 128394; 37.
DR   IntAct; Q8TCJ2; 25.
DR   STRING; 9606.ENSP00000295770; -.
DR   CAZy; GT66; Glycosyltransferase Family 66.
DR   iPTMnet; Q8TCJ2; -.
DR   PhosphoSitePlus; Q8TCJ2; -.
DR   SwissPalm; Q8TCJ2; -.
DR   BioMuta; STT3B; -.
DR   DMDM; 74715800; -.
DR   EPD; Q8TCJ2; -.
DR   MaxQB; Q8TCJ2; -.
DR   PaxDb; Q8TCJ2; -.
DR   PeptideAtlas; Q8TCJ2; -.
DR   PRIDE; Q8TCJ2; -.
DR   Ensembl; ENST00000295770; ENSP00000295770; ENSG00000163527.
DR   GeneID; 201595; -.
DR   KEGG; hsa:201595; -.
DR   UCSC; uc011axe.3; human.
DR   CTD; 201595; -.
DR   DisGeNET; 201595; -.
DR   GeneCards; STT3B; -.
DR   HGNC; HGNC:30611; STT3B.
DR   HPA; HPA036448; -.
DR   HPA; HPA036646; -.
DR   MalaCards; STT3B; -.
DR   MIM; 608605; gene.
DR   MIM; 615597; phenotype.
DR   neXtProt; NX_Q8TCJ2; -.
DR   OpenTargets; ENSG00000163527; -.
DR   Orphanet; 370924; STT3B-CDG.
DR   PharmGKB; PA143485625; -.
DR   eggNOG; KOG2292; Eukaryota.
DR   eggNOG; COG1287; LUCA.
DR   GeneTree; ENSGT00390000015238; -.
DR   HOGENOM; HOG000157471; -.
DR   HOVERGEN; HBG010606; -.
DR   InParanoid; Q8TCJ2; -.
DR   KO; K07151; -.
DR   OMA; XYIAPWS; -.
DR   OrthoDB; EOG091G02DB; -.
DR   PhylomeDB; Q8TCJ2; -.
DR   TreeFam; TF300822; -.
DR   SignaLink; Q8TCJ2; -.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; STT3B; -.
DR   GenomeRNAi; 201595; -.
DR   PRO; PR:Q8TCJ2; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163527; -.
DR   CleanEx; HS_STT3B; -.
DR   Genevisible; Q8TCJ2; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008250; C:oligosaccharyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043686; P:co-translational protein modification; IMP:UniProtKB.
DR   GO; GO:0006516; P:glycoprotein catabolic process; IMP:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; IMP:UniProtKB.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   GO; GO:0006986; P:response to unfolded protein; IMP:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:UniProtKB.
DR   InterPro; IPR003674; Oligo_trans_STT3.
DR   Pfam; PF02516; STT3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Congenital disorder of glycosylation;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase; Magnesium;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    826       Dolichyl-diphosphooligosaccharide--
FT                                protein glycosyltransferase subunit
FT                                STT3B.
FT                                /FTId=PRO_0000246001.
FT   TOPO_DOM      2     64       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     65     85       Helical. {ECO:0000255}.
FT   TOPO_DOM     86    168       Lumenal. {ECO:0000255}.
FT   TRANSMEM    169    189       Helical. {ECO:0000255}.
FT   TOPO_DOM    190    223       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    224    244       Helical. {ECO:0000255}.
FT   TOPO_DOM    245    262       Lumenal. {ECO:0000255}.
FT   TRANSMEM    263    283       Helical. {ECO:0000255}.
FT   TOPO_DOM    284    291       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical. {ECO:0000255}.
FT   TOPO_DOM    313    319       Lumenal. {ECO:0000255}.
FT   TRANSMEM    320    340       Helical. {ECO:0000255}.
FT   TOPO_DOM    341    351       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    352    372       Helical. {ECO:0000255}.
FT   TOPO_DOM    373    410       Lumenal. {ECO:0000255}.
FT   TRANSMEM    411    431       Helical. {ECO:0000255}.
FT   TOPO_DOM    432    440       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    441    461       Helical. {ECO:0000255}.
FT   TOPO_DOM    462    463       Lumenal. {ECO:0000255}.
FT   TRANSMEM    464    484       Helical. {ECO:0000255}.
FT   TOPO_DOM    485    537       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    538    558       Helical. {ECO:0000255}.
FT   TOPO_DOM    559    826       Lumenal. {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TDQ1}.
FT   MOD_RES      18     18       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     498    498       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     499    499       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    616    616       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    623    623       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    627    627       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    641    641       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    822    822       S -> F (in Ref. 4; AAH15880).
FT                                {ECO:0000305}.
SQ   SEQUENCE   826 AA;  93674 MW;  B70C221C7CBEB798 CRC64;
     MAEPSAPESK HKSSLNSSPW SGLMALGNSR HGHHGPGAQC AHKAAGGAAP PKPAPAGLSG
     GLSQPAGWQS LLSFTILFLA WLAGFSSRLF AVIRFESIIH EFDPWFNYRS THHLASHGFY
     EFLNWFDERA WYPLGRIVGG TVYPGLMITA GLIHWILNTL NITVHIRDVC VFLAPTFSGL
     TSISTFLLTR ELWNQGAGLL AACFIAIVPG YISRSVAGSF DNEGIAIFAL QFTYYLWVKS
     VKTGSVFWTM CCCLSYFYMV SAWGGYVFII NLIPLHVFVL LLMQRYSKRV YIAYSTFYIV
     GLILSMQIPF VGFQPIRTSE HMAAAGVFAL LQAYAFLQYL RDRLTKQEFQ TLFFLGVSLA
     AGAVFLSVIY LTYTGYIAPW SGRFYSLWDT GYAKIHIPII ASVSEHQPTT WVSFFFDLHI
     LVCTFPAGLW FCIKNINDER VFVALYAISA VYFAGVMVRL MLTLTPVVCM LSAIAFSNVF
     EHYLGDDMKR ENPPVEDSSD EDDKRNQGNL YDKAGKVRKH ATEQEKTEEG LGPNIKSIVT
     MLMLMLLMMF AVHCTWVTSN AYSSPSVVLA SYNHDGTRNI LDDFREAYFW LRQNTDEHAR
     VMSWWDYGYQ IAGMANRTTL VDNNTWNNSH IALVGKAMSS NETAAYKIMR TLDVDYVLVI
     FGGVIGYSGD DINKFLWMVR IAEGEHPKDI RESDYFTPQG EFRVDKAGSP TLLNCLMYKM
     SYYRFGEMQL DFRTPPGFDR TRNAEIGNKD IKFKHLEEAF TSEHWLVRIY KVKAPDNRET
     LDHKPRVTNI FPKQKYLSKK TTKRKRGYIK NKLVFKKGKK ISKKTV
//
